The stability of polymers with C—C and stable C—heteroatom backbones against chemicals, hydrolysis, temperature, light, and microbes has challenged society with the problem of accumulation of plastic waste and its management worldwide. Given careless disposal of plastic waste, large amounts of plastic litter accumulate in the environment and disintegrate into microplastics. One of the questions frequently raised in the recent times is if so‐called biodegradable polymers can substitute conventional polymers for several applications and help to tackle this challenge. The answer is not so simple as biodegradability is a certified property occurring only under certain environmental conditions and therefore requires systematic study. As a first step, this study focusses on comparative degradation studies of six polymers (five taken from the so‐called biodegradable polyesters, including poly(lactic‐ co ‐glycolic acid) (PLGA), polycaprolactone (PCL), polylactic acid (PLA), poly(3‐hydroxybutyrate) (PHB), Ecoflex, and one well‐known non‐degradable polymer poly(ethylene terephthalate) (PET) in artificial seawater and freshwater under controlled conditions for 1 year. Only amorphous PLGA shows 100% degradation as determined by weight loss, change in molar mass with time, NMR, electron microscopy, and high‐performance liquid chromatography. This is a step forward in understanding the degradability of polyesters required for the design of environmentally friendly novel polymers for future use.

Achieving high drug loading capacity and controlling drug delivery are two main challenges related to drug carriers. In this study, polymeric macroporous sponges with very high pore volume and large porosity are introduced as a new-type of drug carrier. Due to the high pore volume (285 and 166 cm/g for the sponges with densities of 3.5 and 6.0 mg/cm, respectively), the sponges exhibit very high drug loading capacities with average values of 1870 ± 114 and 2697 ± 73 mg/g in the present study, which is much higher than the meso and microporous drug carriers (<1500 mg/g). In order to control the release profiles, an additional poly(p-xylylene) (PPX) coating was deposited by chemical vapor deposition on the drug loaded sponge. Consequently, Artemisone (ART) release in the aqueous medium could be retarded, depending on the density of the sponge and the thickness of the coating. In future, the new 3D polymeric sponges would be highly beneficial as drug carriers for the programmed release of drugs for treatment of chronic diseases.

No abstract

A programmable release system with wide range of release profiles of the antimalarial artemisone (ART) from fibrous nanocarriers (NFN) is presented. This is achieved following a new paradigm of using ART‐loaded NFN in infusion system of hydrophobic drug eluting nanocarriers, adapted to clinical applications. Very importantly, under these conditions ART did not degrade as it was observed in solution.